Search Results 271-280 of 2954 for ✍원벳원 [원탑보증.com/가입코드 111] 올인구조대 ✍

  1. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

    Cabozantinib-s-malate and sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known ...

  2. Mayo Clinic

    ... . VID-20453014. Home; General GI Marketing Video. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact ...

  3. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

    To evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R2-CHOP) chemotherapy versus placebo ...

  4. A Study of the Health Issues of Bleeding Disorders - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx - Mayo Clinic

    This expanded access therapeutic protocol aims to allow patients suffering from inoperable, somatostatin receptor positive, neuroendocrine tumors, progressive ...

  7. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

    This randomized phase II clinical trial studies how well nivolumab after combined modality therapy works in treating patients with high risk stage II-IIIB anal ...

  8. A New Hand-held Electronic Device Tool for Self-assessment of Neurological Disability: Mayo Clinic Electronic Emoji Based Neurological Impairment Status (MEBNIS)

    The purpose of this study is: To develop an Emoji Based Neurological Impairment Status scale to assess the patient neurological status; To determine the level ...

  9. Family History - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    The eMERGE Genome Informed Risk Assessment study at Mayo Clinic takes participants' family histories into account to estimate their risk of developing ...

  10. First-in-Human Study of KO-947 in Non-Hematological Malignancies - Mayo Clinic

    If an MTD cannot be identified, a recommended phase 2 dose (RP2D) will be determined. In addition, two tumor specific extension cohorts may be conducted to ...